ArticleShock (Augusta, Ga.)2014

Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.

Kazuhiro Shirozu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.